Clinical trial
Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting…
NCT00110370 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00110370 |
|---|---|
| Title | Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 Diabetes |
| Official title | A Comparison of Prandial Insulin Lispro Mixtures Therapy to Glargine Basal-Bolus Therapy With Insulin Lispro on the Overall Glycemic Control of Patients With Type 2 Diabetes Previously Treated With Oral Agents Combined With Insulin Glargine |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Lispro Mixture Therapy, Glargine Basal-Bolus Therapy |
| Enrollment | 300 |
| Start date | Apr 1, 2004 |
| Completion | Apr 1, 2006 |
| First posted | May 9, 2005 |
| Last update posted | Nov 27, 2007 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: